Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Richard Larouche, M.D
Woman and Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicef 300 mg Capsule Fasting Conditions
To demonstrate the relative bioequivalence of Cefdinir and Omnicel 300 mg capsule fasting conditions.
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions
The objective of this study is to compare the rate and extent of absorption of bicalutamide 50 mg tablet (test) versus Casodex (reference), administered as 1 x 50 mg tablet under fasting c...
Country
Canada
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions
The purpose of this bioequivalence study is to compare the test of Rivastigmine 1.5 mg Capsules of Dr.Reddy's Laboratories Limited with reference to Exelon 1.5 mg of Novartis in Healthy Su...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
The objective of this study is to compare the rate and extent of absorption of ramipril 10 mg capsule (test) versus Altace® (reference), administered as 1 x 10 mg capsule under fasting con...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
The purpose of this study is to demonstrate the relative bioavailability of Bicalutamide 50 mg tablet and Casodex following a 50 mg dose in healthy subjects under fasting conditions.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions
To demonstrate the relative bioequivalence of Cefdinir and Omnicel 300 mg capsule fed conditions.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Richard Larouche, M.D
Update Il y a 4 ans
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions
To demonstrate the relative bioequivalence of Cefdinir and Omnicel 250mg/5 ml fasting conditions.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2